Lefamulin

• Streptococcus pneumoniae

• Staphylococcus aureus

• Haemophilus influenzae

• Legionella pneumophila

• Mycoplasma pneumoniae

• Chlamydophila pneumoniae

lefamulin should be considered in pregnant women until better safety data are available. Females with reproductive potential should use contraception while on therapy and for 2 days after the last dose.

Animal lactation studies suggest that lefamulin concentrates in breast milk. It is advised that lactating women taking lefamulin pump and discard while taking lefamulin and for 2 days after the last dose.